• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Orange Book: Approved Drug Products with Therapeutic Equivalence Evaluations

  • Print
  • Share
  • E-mail
-

Patent and Exclusivity Search Results from query on Appl No 022291 Product 003 in the OB_Rx list.


Patent Data

Appl No Prod No Patent No Patent
Expiration
Drug Substance
Claim
Drug Product
Claim
Patent Use
Code
Delist
Requested
N022291 003 6280959 Oct 30, 2018 Y Y U - 1306
N022291 003 6280959 Oct 30, 2018 Y Y U - 930
N022291 003 6280959 Oct 30, 2018 Y Y U - 1575
N022291 003 7160870 Nov 20, 2022 Y Y U - 1575
N022291 003 7160870 Nov 20, 2022 Y Y U - 930
N022291 003 7160870 Nov 20, 2022 Y Y U - 1306
N022291 003 7332481 May 24, 2021 U - 1306
N022291 003 7332481 May 24, 2021 U - 1575
N022291 003 7332481 May 24, 2021 U - 930
N022291 003 7452874 May 24, 2021 Y Y
N022291 003 7473686 May 24, 2021 Y Y U - 930
N022291 003 7473686 May 24, 2021 Y Y U - 1306
N022291 003 7473686 May 24, 2021 Y Y U - 1575
N022291 003 7547719 Jul 13, 2025 Y Y U - 1575
N022291 003 7547719 Jul 13, 2025 Y Y U - 930
N022291 003 7547719 Jul 13, 2025 Y Y U - 1306
N022291 003 7790704 May 24, 2021 U - 1306
N022291 003 7790704 May 24, 2021 U - 1575
N022291 003 7790704 May 24, 2021 U - 930
N022291 003 7795293 May 21, 2023 U - 930
N022291 003 7795293 May 21, 2023 U - 1575
N022291 003 7795293 May 21, 2023 U - 1306
N022291 003 8062665 Aug 1, 2027 Y U - 930
N022291 003 8062665 Aug 1, 2027 Y U - 1575
N022291 003 8062665 Aug 1, 2027 Y U - 1306

Exclusivity Data

Appl No Prod No Exclusivity Code Exclusivity Expiration
N022291 003 I - 664 Nov 16, 2015
N022291 003 NCE Nov 20, 2013
N022291 003 ODE Nov 20, 2015
N022291 003 ODE Aug 26, 2021


Additional information:

  1. Patents are published upon receipt by the Orange Book Staff and may not reflect the official receipt date as described in 21 CFR 314.53(d)(5).
  2. Patents listed prior to August 18, 2003 are flagged with method of use claims only as applicable and submitted by the sponsor. These patents may not be flagged with respect to other claims which may apply.


View a list of all patent use codes
View a list of all exclusivity codes

Return to Electronic Orange Book Home Page


FDA/Center for Drug Evaluation and Research
Office of Generic Drugs
Division of Labeling and Program Support
Update Frequency:

Orange Book Data - Monthly
Generic Drug Product Information & Patent Information - Daily
Orange Book Data Updated Through October 2014
Patent and Generic Drug Product Data Last Updated November 21, 2014

-
-